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Olive oil decreases the risk of CVD. This effect may be due to the fatty acid profile of the oil, but it may also be due to its antioxidant content which
differs depending on the type of olive oil. In this study, the concentrations of oleic acid and antioxidants (phenolic compounds and vitamin E) in
plasma and LDL were compared after consumption of three similar olive oils, but with differences in their phenolic content. Thirty healthy volunteers
participated in a placebo-controlled, double-blind, crossover, randomized supplementation trial. Virgin, common, and refined olive oils were admi-
nistered during three periods of 3 weeks separated by a 2-week washout period. Participants were requested to ingest a daily dose of 25 ml raw olive
oil, distributed over the three meals of the day, during intervention periods. All three olive oils caused an increase in plasma and LDL oleic acid
(P,0·05) content. Olive oils rich in phenolic compounds led to an increase in phenolic compounds in LDL (P,0·005). The concentration of phenolic
compounds in LDL was directly correlated with the phenolic concentration in the olive oils. The increase in the phenolic content of LDL could account
for the increase of the resistance of LDL to oxidation, and the decrease of the in vivo oxidized LDL, observed in the frame of this trial. Our results
support the hypothesis that a daily intake of virgin olive oil promotes protective LDL changes ahead of its oxidation.
Olive oil: Oleic acid: Phenolic compounds: LDL: CVD risk
CVD is the main cause of death and disability in developed
countries1 – 3. The type of fat consumed can modify the
plasma and LDL lipid profile, which is directly related to
the growth of atheroma plaque4,5. However, the antioxidant
content of the diet is also crucial, as oxidized LDL seems to
be involved in atherosclerotic plaque development6.
Olive oil, rich in MUFA and antioxidant minor components,
is considered to be favourable for cardiovascular health7 – 12.
Linoleic acid (C18: 2) accounts for 90 % of the PUFA present
in LDL and is the main substrate for oxidation. However, diets
rich in oleic acid, like those in Mediterranean countries, gen-
erate LDL particles which appear to be more resistant to oxi-
dation3,5,13 – 17. Moreover, data from in vitro18,19 and in vivo
studies20 – 23 show that the phenolic compounds of olive oil
protect LDL from lipid peroxidation. Thus, olive oil phenolic
compounds are good candidates to partially account for the
prevention provided by diet against CVD. Due to this, studies
directed at a better understanding of the protective mechan-
isms of olive oil on human health must be enhanced.
To date, few studies have analysed the effects of sustained
olive oil consumption on human LDL composition. The few
available data come from short-term studies20,24,25 or non-ran-
domized trials where only virgin olive oil was used25.
A double-blind, randomized, crossover, controlled trial was
carried out to identify the effect of similar olive oils, but with
a range of phenolic content, on the levels of plasma and LDL
antioxidants and oleic acid in healthy subjects. Volunteers
from a religious centre, a population with regular and similar
lifestyles such as physical activity and dietary habits, were
involved. In the frame of this trial we have previously reported21
a protective effect of an olive oil rich in phenolic compounds on
LDL oxidation. From these results, our main hypothesis was that
sustained real-life doses (25 ml/d) of raw rich phenolic olive oil
could enhance the antioxidant load of the LDL, thus protecting
the lipoproteins from oxidation. Here, we examined the fatty
acid and antioxidant composition of the LDL after consumption
of similar olive oils, but with differences in their phenolic con-
tent, in order to test our hypothesis.
Materials and methods
Study population
An in-person screening visit was conducted to ascertain eligi-
bility and obtain baseline data. Forty-two subjects from a reli-
gious community were screened for inclusion. Nine of them
were ineligible. Thus, thirty-three healthy volunteers, from
23 to 91 years old, with a regular lifestyle and dietary habits
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were included. The volunteers gave their written consent prior
to participating in the study. Subjects with any of the follow-
ing conditions were excluded: smoking; intake of any drug or
supplements with established antioxidative properties, either
in the two weeks before the onset of the study or throughout
the study; obesity (BMI .30 kg/m2); diabetes; and any dis-
ease or condition that would impair compliance.
Diets were prepared and consumed in the religious centre.
Subjects maintained their regular physical activity and life-
style throughout the study. The local institutional Review
Board approved the protocol according to the Helsinki
Declaration of 1975.
Olive oil composition
Three olive oils provided by the Olive Oil Cooperative Associ-
ation of Catalonia were used. They were obtained from the
same harvest which means that olive fruits were of the same
cultivar, collection time, and soil. First, a virgin olive oil
with a phenolic content of 825mmol caffeic acid equivalents
(CAE)/kg was selected. Then, we used a refined (phenolic con-
tent of 0mmol/kg) and a common olive oil (phenolic content
of 370mmol CAE/kg) with similar fatty acid composition,
a-tocopherol and b-carotene content, in order to match the
virgin olive oil. Major and minor components of the three
olive oils were examined in order to confirm their similar
fatty acid and micronutrient profile, as well as the differences
in their phenolic content. The characteristics of the oils are
summarized in Table 1. The acidity value, the peroxide
index, and the UV spectrophotometric index (K270) were
determined following the analytical methods described in the
European Union Commission Regulation CE/1989/200326.
Fatty acids were transformed into methyl esters and analyzed
by gas chromatography26. a-Tocopherol was measured by
HPLC, as previously described27. Phenolic compounds were
measured by the Folin-Ciocalteau method25,28,29.
Study design
A placebo-controlled, double-blind, crossover, randomized,
supplementation trial was conducted. A Latin square for the
three treatments was used in the crossover trial, to randomize
participants into three orders of olive oil administration:
virgin–common–refined (order 1), common–refined–virgin
(order 2), and refined–virgin–common (order 3). The three
olive oils were administered over three periods of 3 weeks,
each one preceded by 2-week washout periods (Fig. 1). Par-
ticipants were requested to ingest a daily raw dose of 25 ml
olive oil, distributed over the three meals of the day, during
intervention periods. Refined olive oil was used as source of
raw fat in washout periods. Other cooking fats were replaced
by refined olive oil to maintain energy and oleic acid intake
unchanged during the entire study.
Daily menus were recorded, as were extra food intakes
between meals, and meals eaten outside the religious centre.
Participants were requested to avoid a high intake of foods
containing phenolic compounds such as fruit, vegetables, tea
and red wine. Participants were managed by a trained phys-
ician who stayed at the religious centre throughout the
study. Participants were instructed to return the 25 ml contain-
ers every morning when they collected their next daily dose, in
order to register the amount of unconsumed oil. Treatment
containers for the daily dose of olive oil to be ingested in
the intervention periods were coded, concealed from partici-
pants, and distributed by investigators to the participants. Con-
tainers were opaque in order to conceal the olive oil and to
avoid its degradation.
Diets were analyzed by a nutritionist and converted into
nutrients using the software Medysystems (Conaycyte S.A,
Madrid, Spain)30. Anthropometric variables (i.e. height and
weight) were recorded. Physical activity was assessed by the
Minnesota Leisure Time Physical Activity Questionnaire,
which has been validated for use on Spanish men31.
Sample size and power analyses
The sample size was calculated to provide a statistical power
of 80 %. In order to recognize as statistically significant a
difference $10 min change in lag time, and a change of
4 nmol/mg apo B of phenolic compounds in LDL, ten and
nine subjects were necessary in each order of olive oil admin-
istration respectively. It was assumed that standard deviations
were 10 min and 4 nmol/mg apo B for lag time and phenolic
compounds in LDL, respectively.
Blood sampling and laboratory analyses
Laboratory measurements were carried out on samples from
fasting subjects taken: before the first washout period (base-
line); before administration of the three types of oil; and
after olive oil administration. To prevent oxidation and aggre-
gation of LDL, blood samples were drawn with EDTA tubes
(1 g/l) and stored with saccharose (0·18 mM) at 2808C.
Plasma was separated by centrifugation at 1000 g at 48C for
15 min. LDL isolation was performed by sequential flotation
ultra centrifugation32. All samples were stored at 2808C
until analysis.
Table 1. Olive oil composition
Refined Common Virgin
Quality parameters
Free acidity (% oleic acid) 0·12 0·17 0·11
Peroxide value (meq O2/kg oil) 1·80 2·93 6·48
K270 0·480 0·201 0·102
Fatty acids (%)
C14:0 0·02 0·02 0·01
C16:0 11·25 11·78 13·18
C16:1 0·86 1·05 1·11
C17:0 0·08 0·06 0·10
C17:1 0·15 0·13 0·22
C18:0 2·52 2·59 1·76
C18:1 73·46 75·65 73·37
C18:2 9·97 7·17 9·02
C20:0 0·45 0·39 0·33
C18:3 0·73 0·70 0·48
C20:1 0·34 0·29 0·28
C22:0 0·12 0·10 0·10
C24:0 0·05 0·04 0·04
MUFA(%) 74·83 77·14 74·98
PUFA(%) 10·68 7·86 9·50
SFA(%) 14·49 15·00 15·52
Phenolic compounds (mmol/kg CAE) 0 370 825
a-Tocopherol (mol/kg) 65·88 48·22 47·98
CAE, Caffeic acid equivalents; K270, UV spectrophotometric index.
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Total cholesterol, HDL-cholesterol and TAG levels were
measured by standard enzymatic methods. The fatty acid com-
position of plasma and LDL was measured by the method
described by Rodrı´guez-Palmero et al.33. Fatty acid methyl
esters were prepared by alkaline hydrolysis with sodium meth-
ylate and esterification with boron trifluoride in methanol.
Fatty acid methyl esters were extracted with hexane and
injected into a gas chromatograph. The CV obtained ranged
from 3·42 to 5·25 %. To determine a-tocopherol in plasma
and LDL, an aliquot of the sample was deproteinized with
ethanol. The analyte was then extracted with hexane and
injected into an HPLC system. The CV was 4·27 %34. Phenolic
compounds in LDL were also determined by HPLC-Diode
Array Detection, as previously described35. Briefly, acidulated
LDL was applied to a Waters OasisTM HLB extraction car-
tridge (Milford, MA, USA) and washed with water and 5 %
aqueous methanol. Phenolic compounds, measured only in
LDL, were eluted with methanol, which was then evaporated
under a stream of nitrogen. The residue was dissolved in
acidulated water and injected into an HPLC system. The chro-
matogram was monitored at 280 nm and the areas of phenolic
compounds were expressed as CAE. The analytical within-run
precision was 5·25 %, and the between-run precision was
8·8 %. Oxidized LDL was measured in plasma by ELISA
(ox-LDL, Mercodia AB, Uppsala, Sweden). The LDL resist-
ance to oxidation was determined by formation of conjugated
dienes after copper (5mM) oxidation of isolated LDL18.
Results of LDL parameters were expressed according to apo
B. Apo B concentrations were measured by immunoturbidi-
metry (Roche Diagnostics, Basel, Switzerland).
Hydroxytyrosol and tyrosol, the major olive oil phenolic
compound, were measured in urine, by HPLC, as markers of
compliance of the interventions. Analytical within-run pre-
cision and between-run precision were 2·9 and 3·8 %, and
5·7 and 6·2 % for tyrosol and hydroxytyrosol, respectively36.
Statistical methods
The normality of variable distribution was assessed by the
Kolmogorov–Smirnov test and by an analysis of skewness
and kurtosis. One-factor ANOVA and the Kruskal–Wallis
test were used to analyze the differences in baseline character-
istics among the three groups, by order of olive oil adminis-
tration. A general linear model for repeated measurements,
with Tukey’s correction for multiple comparisons, was used
to assess washout effectiveness and the effect of each type of
oil. The possible carryover effect was checked by testing a
period-by-treatment interaction term in the model. Statistical
significance was defined as P,0·05 for a two-sided test.
SPSS 11.0 statistical software (SPSS Inc., Chicago, IL,
USA) was used.
Results
Participants’ characteristics
The subject pool at randomization consisted of thirty-three
subjects. Two of these were withdrawn because of a post-ran-
domization criterion of ineligibility (hypercholesterolemia),
and one participant requested to be withdrawn. Thus, finally
thirty subjects participated in the study. Baseline character-
istics (at the beginning of the study) of the subjects are pre-
sented in Table 2 according to the randomized order.
Negligible differences in baseline characteristics were
observed among the three randomly formed groups. The
mean age of participants was 57·13 (SD 19·54) years and
the BMI was 22·92 (SD 5·15) kg/m2. We did not observe
changes in physical activity from baseline to the end of
the study.
Adverse effects
No collateral effects which could influence the participation in
the study or the compliance of the participants occurred during
the study period. No adverse effects were observed related to
olive oil ingestion.
Dietary intake and adherence
The average of the main antioxidant (i.e. b-carotenoid, vita-
min C, a-tocopherol), or pro-oxidant (i.e. Fe) intake, energy,
and any nutrient of interest were similar in the three groups
during each type of olive oil intervention (Table 3). Partici-
pants’ alcohol intake was ,30 g/d. Tyrosol and hydroxytyro-
sol in urine increased in a dose-dependent manner with the
phenolic content of olive oil administered. Mean changes
were 15 %, 147 %, and 190 % for tyrosol, and 12 %, 180 %,
and 221 % for hydroxytyrosol, after refined, common,
and virgin olive oil, respectively21.
Plasma and LDL fatty acid and antioxidant content
The phenolic content of LDL was significantly higher after the
virgin olive oil administration than at baseline (P,0·005) and
Fig. 1. Time-line for the study design. B, Baseline; WO, wash-out.
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pre-virgin olive oil consumption (P,0·01), without significant
changes after refined or common olive oil interventions
(Table 4 and Fig. 2). When the relative changes (as percen-
tage) were assessed, phenolic compounds in LDL followed
an increasing trend (P,0·05) from refined to common to
virgin olive oil. The increase in phenolic compounds in
LDL after virgin olive oil intervention reached significance
v. that after refined olive oil intervention (P,0·005).
We did not observe any changes in oleic acid and a-toco-
pherol in plasma or in a-tocopherol in LDL among olive oil
interventions. In comparison with baseline values, levels of
oleic acid increased after common and virgin olive oil inter-
ventions (Table 4). No carryover effect was observed in any
variable of interest, with the exception of oleic acid in
plasma and LDL. As expected, an increase in the time-
sequence for oleic acid values was observed (P,0·05). As
has been previously described, a protective effect of olive
oil phenolic compounds on LDL oxidation was observed21.
The resistance of LDL to oxidation induced by copper lag
time for copper-mediated LDL oxidation increased, and the
levels of in vivo oxidized LDL decreased in a dose-dependent
manner with the phenolic content of the olive oil administered
(P,0·05). Mean changes were 3·2 %, 25·2 %, and 228·2 %
for in vivo oxidized LDL, and 2·3, 4·5 %, and 5·5 % for the
in vitro lag time of LDL oxidation, after refined, common,
and virgin olive oil, respectively. Changes in the lipid profile
after the olive oil interventions are reflected in Fig. 3. An
increase in HDL cholesterol after virgin olive oil consumption
was observed (P ¼ 0·029)21.
Discussion
In Mediterranean countries, dietary fat accounts for more than
the 30 % of energy mostly provided by the MUFA from
olive oil. The main olive oils used for dietary purposes
in Mediterranean countries are virgin olive oil, obtained exclu-
sively by physical procedures and rich in phenolic compounds,
and common olive oil26 which is a mixture of refined
Table 2. Baseline characteristics by sub-groups of subjects depending on the order* of olive oil administration
(Mean values and standard deviations)
Order 1 Order 2 Order 3
Clinical parameter Mean SD Mean SD Mean SD P
Age (year) 54·8 21·4 61·0 19·2 56·6 19·3 0·80
BMI (kg/m2) 24·2 3·5 23·2 3·3 23·6 2·9 0·22
Waist:hip ratio 0·92 0·05 0·89 0·04 0·89 0·05 0·40
TAG (mmol/l) 1·1 0·5 1·2 0·4 1·0 0·5 0·68
Total cholesterol (mmol/l) 5·4 1·1 5·7 1·0 5·9 1·2 0·25
HDL cholesterol (mmol/l) 1·4 0·3 1·4 0·3 1·5 0·3 0·66
Glucose (mmol/l) 4·4 0·7 4·2 0·5 4·6 0·9 0·59
Plasma a-tocopherol (mmol/ml) 4·2 £ 1022 1·38 £ 1022 4·7 £ 1022 1·2 £ 1022 5·1 £ 1022 1·1 £ 1022 0·22
Plasma oleic acid (mmol/l) 2·1 0·5 2·0 0·9 2·0 0·6 0·77
LDL a-tocopherol (mmol/mg apo B) 2·1 £ 1022 0·31 £ 1022 1·9 £ 1022 0·38 £ 1022 1·7 £ 1022 0·45 £ 1022 0·59
LDL phenolic compounds (nmol CAE/mg apo B) 8·7 3·2 7·9 2·3 7·8 1·5 0·29
LDL oleic acid (mmol/mg apo B) 0·31 0·1 0·25 0·05 0·31 0·1 0·34
Physical activity (kJ/d) 1410 966 1648 879 1886 1518 0·62
CAE, Caffeic acid equivalents.
* Orders of olive oil administration: Order 1, virgin–common–refined (n 11); Order 2, common–refined–virgin (n 9); Order 3, refined–virgin–common (n 10).
Table 3. Daily intake of nutrients in each dietary period
(Mean values and standard deviations for thirty subjects)
Olive oil administered
Refined
(0 mg/mmol/kg CAE)
Common
(370mmol/kg CAE)
Virgin
(825mmol/kg CAE)
Mean SD Mean SD Mean SD P
Energy (kJ) 9567 937 9639 1079 9668 966 0·84
Protein (%) 20·4 1·8 20·2 1·8 20·3 1·6 0·70
Fat (%) 37·5 4·1 37·7 4·5 40·0 4·8 0·60
Carbohydrate (%) 41·9 5·1 41·8 4·9 41·6 5·5 0·89
MUFA (%) 20·2 2·8 20·1 2·9 20·2 2·8 0·96
PUFA (%) 4·5 0·5 4·4 0·5 4·4 0·4 0·55
SFA (%) 13·9 2·0 13·9 2·2 13·8 1·9 0·82
a-tocopherol (mg)* 8·4 1·9 8·3 2·4 8·6 2·3 0·66
Vitamin C (mg) 227 99 228 102 229 97 0·75
Phenolic compounds (mg)* 14·9 4·8 14·4 5·3 14·7 5·8 0·66
b-Carotene (mg) 2385 354 2337 361 2420 332 0·74
CAE, phenolic content in caffeic acid equivalents.
* This amount excludes the phenolic compounds and a-tocopherol taken with the oils studied.
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(phenolic-free) and virgin olive oil. In this study, and using
three types of olive oil with high (virgin), medium
(common), and null (refined) phenolic content, we observed
an increase in the LDL phenolic compound content of healthy
human volunteers, in a dose-dependent manner with the phe-
nolic content of the olive oil administered. This increase in the
phenolic content of the LDL was concomitant with a decrease
of the in vivo degree of LDL oxidation, and an increase in the
ex vivo resistance of LDL to oxidation. A dose-dependent
decrease of the oxidative lipid damage with the phenolic con-
tent of the olive oil has been recently reported20. Plasma con-
centration of oxidized LDL has been shown to be predictive
for CVD events in a general population37. Thus, interventions
directed at controlling this variable are useful tools in the pri-
mary and secondary prevention of CVD.
As is reflected in this study and others, olive oil phenolic
compounds are absorbed in human subjects38 – 41 in a dose-
dependent manner with the phenolic content of the olive
oil20,21,42. Phenolic compounds from olive oil can bind the
human LDL after virgin olive oil ingestion43,44. In a previous
study, we observed that the postprandial LDL total phenolic
content and LDL oxidation could be modulated by olive oil
phenolic compounds in human subjects20. Here, we report
the same phenomenon after a sustained consumption of
olive oil.
At baseline, subjects did not consume only olive oil as a
source of fat. Instead, they consumed preferentially other veg-
etable oils for cooking, using olive oil for raw purposes. The
increase in oleic acid in LDL observed throughout the study
could be due to the consumption of all types of olive oil,
given that the refined olive oil was consumed during the wash-
out periods. From our results, olive oil consumption promoted
an increase of MUFA in the LDL. MUFA are less susceptible
to oxidation than PUFA3,45. Due to this, the increase of
MUFA in LDL could enhance the preservation of the phenolic
compounds bound to LDL, given that they are not used to
counteract the autocatalytic chain reaction of LDL fatty acid
peroxidation46. This fact could also explain the non-significant
increase in LDL phenolic compounds observed after refined
olive oil intervention, compared with baseline values.
Phenolic compounds can protect LDL from oxi-
dation20,21,44,47 – 50 through different mechanisms: (1) for the
free radical scavenging properties (the capacity of hydrogen-
donation and their ability to improve radical stability)51 – 53;
(2) by means of the strong metal-chelation capacity54; (3)
through the nitric oxide stimulation in endothelial cells55,56;
(4) by stimulating antioxidant transcription and detoxification
defence systems42,57,58, and (5) by modulating other
enzymatic systems related with oxidation process (cyclooxy-
genases, lipooxigenases and NAD(P)H oxidase)53. In addition,
olive oil phenolic compounds have been shown to be related
with the prevention of platelet aggregation49,59, vasodilata-
tion22, and anti-inflammation22,59 – 61, Thus, the protection
provided by the olive oil phenolic compounds on CVD risk
may be due to a combination of bioactive mechanisms.
Phenolic compounds of dietary origin have been shown to
be involved in cholesterol and lipoprotein metabolism60.
Table 4. Content in a-tocopherol, phenolic compounds and oleic acid at baseline and after each dietary period
(Mean values and standard deviations for thirty subjects)
Baseline
Post-consumption of
refined olive oil
Post-consumption of
common olive oil
Post-consumption of
virgin olive oil
Mean SD Mean SD Mean SD Mean SD
Plasma
a-Tocopherol (mmol/ml) 4·8 £ 1022 1·1 £ 1022 4·6 £ 1022 1·2 £ 1022 4·4 £ 1022 1·5 £ 1022 4·4 £ 1022 1·1 £ 1022
Oleic acid (mmol/l) 2·02 0·10 2·05 0·07 2·12 0·07 2·05 0·10
LDL
a-Tocopherol (mmol/mg apo B) 1·90 £ 1022 0·49 £ 1022 1·95 £ 1022 0·58 £ 1022 1·94 £ 1022 0·53 £ 1022 1·92 £ 1022 0·51
Phenolic compounds
(nmol CAE /mg apo B)
7·88 2·55 9·16 3·7 9·55 4·27 10·44*† 4·0
Oleic acid (mmol/mg apo B) 0·31 0·14 0·32 0·12 0·39* 0·14 0·39 0·14
* Mean values were significantly different from baseline values (P,0·005).
†P , 0·05 for linear trend from refined to common to virgin olive oil.
Fig. 2. Phenolic content in LDL at the beginning of the study (baseline) and
before (A) and after (B) each olive oil intervention. Values are means with
their standard deviations shown by vertical bars. CAE, caffeic acid equiva-
lents. Mean values were significantly different from those at baseline after
the virgin olive oil administration a (P,0·005). Mean values were significantly
different between pre- and post- virgin olive oil consumption b(P,0·01).
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In this study, we observed an increase in HDL cholesterol
levels after virgin olive oil intervention. These results are in
line with the recent results of the EUROLIVE study62, a
large inter-country intervention trial with three similar types
of olive oils, but with differences in their phenolic content.
Results of the EUROLIVE study showed a dose-dependent
increase of the plasma HDL cholesterol levels with the pheno-
lic content of the olive oil administered. Mechanisms by
which phenolic compounds can enhance HDL cholesterol
are at present unknown.
Phenolic compounds in olive oil may contribute to the
health benefits63,64 and a Mediterrranean diet, rich in virgin
olive oil, improves protection against the major risk factors
for CVD65,66.
The design and conduct of the study had strengths and limi-
tations. One strength was that the dose administered, 25 ml/d,
closely reflects real-life consumption in Southern European
Mediterranean countries. Another was the crossover design,
which permitted the same participants to receive all olive
oils, thereby minimizing interferences with confounding
variables. Our design, however, did not allow modelling the
first- and second-order possible carryover effects. Another
limitation was the inability to assess potential interactions
between olive oil and other diet components. Measurements
of dietary intake relied on self-reporting and were, therefore,
subjective. Another limitation is the short duration of the inter-
vention periods. It is unknown whether additional or different
effects would have been observed over longer periods. A
longer duration of the study, however, could have impaired
the compliance of the participants. Also, although the trial
was blinded, some participants might have identified the
refined olive oil by its taste and smell.
In summary, regular consumption of olive oil increases the
MUFA content of the LDL lipoprotein. Regular consumption
of olive oil rich in phenolic compounds increases the LDL
total phenolic content in a dose-dependent manner with
the phenolic content. The combined protective effect of the
MUFA and phenolic content of the LDL could account
for the decrease in LDL oxidation observed in the frame of
this study.
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